Tag: #Global Trends

Japanese drugmaker Takeda has officially announced positive top-line readouts from a head-to-head clinical trial, demonstrating that its investigational autoimmune candidate,... Read more

Johnson & Johnson (J&J) has unveiled positive data from its pivotal Phase 2/3 clinical trial, designated as the Energy study,... Read more

Danish pharmaceutical giant Novo Nordisk has officially issued a security incident notice confirming a targeted cyberattack that compromised specific components... Read more

DKSH has officially entered into a definitive strategic distribution and commercialization partnership with BridgeBio, a U.S. biotechnology innovator focused on... Read more

The National Institute for Health and Care Excellence (NICE) has published final draft guidance enabling AbbVie’s Aquipta (atogepant) to be... Read more

German life science enterprise Bayer has officially announced that the European Medicines Agency (EMA) has validated and initiated its centralized... Read more

U.S. biotechnology innovator Parabilis Medicines has successfully secured the largest initial public offering (IPO) in global biotech history. The landmark... Read more

Organon has officially announced that the U.S. Food and Drug Administration (FDA) has approved the expanded clinical utilization of its... Read more

U.S. pharmaceutical titan Pfizer is officially reviewing the timeline and physical scope of its planned investments within Germany. The corporate... Read more